Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17827480 | 0.97 | ALOX5 (0.33) | ALOX5 | |
| SCHEMBL17855922 | 0.95 | ALOX5 (0.31) | ALOX5 | |
| SCHEMBL17855611 | 0.91 | ALOX5 (0.32) | ALOX5 | |
| SCHEMBL17855412 | 0.91 | ALOX5 (0.30) | ALOX5 | |
| SCHEMBL17855597 | 0.90 | ALOX5 (0.33) | ALOX5 | |
| SCHEMBL21040557 | 0.90 | F9 (0.30) | — | |
| SCHEMBL17827432 | 0.90 | ALOX5 (0.31) | ALOX5 | |
| SCHEMBL17805037 | 0.90 | — | — | |
| SCHEMBL17804975 | 0.89 | ALOX5 (0.35) | ALOX5 | |
| SCHEMBL17805138 | 0.88 | ALOX5 (0.34) | ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10756275-B2 | Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic equipment | IDEMITSU KOSAN CO., LTD. (JP) | 2020-08-25 | — | — | US | disclosed |
| US-9929355-B2 | Amine compound and organic electroluminescent device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-27 | — | — | US | disclosed |
| US-9929355-B2 | Amine compound and organic electroluminescent device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-27 | — | — | US | disclosed |
| US-20160197277-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-07 | — | — | US | disclosed |
| US-20160197277-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-07 | — | — | US | disclosed |
| US-20160172593-A1 | AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-16 | — | — | US | disclosed |
| US-20160172593-A1 | AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-16 | — | — | US | disclosed |
| EP-3029023-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | Idemitsu Kosan Co., Ltd (JP) | 2016-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10756275-B2 | Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic equipment | CHRM1, L1CAM, ESR1 | ALOX5 1925/4885 |
| US-20160197277-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT | CHRM1, L1CAM, ESR1 | ALOX5 1925/4885 |
| US-20160172593-A1 | AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | AOC2, SAT1, ODC1 | ALOX5 1438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.